429
Views
8
CrossRef citations to date
0
Altmetric
Oncology

The effect of information on preferences for treatments of metastatic renal cell carcinoma

, , , , , & show all
Pages 1827-1838 | Received 04 Feb 2016, Accepted 04 Jul 2016, Published online: 11 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rosalba Rosato, Daniela Di Cuonzo, Giuliana Ritorto, Laura Fanchini, Sara Bustreo, Patrizia Racca & Eva Pagano. (2020) Tailoring chemotherapy supply according to patients’ preferences: a quantitative method in colorectal cancer care. Current Medical Research and Opinion 36:1, pages 73-81.
Read now

Articles from other publishers (7)

Ruilin Ding, Rong Shao, Lingli Zhang & Jianzhou Yan. (2023) Preferences and Willingness to Pay for Medication in Patients with Renal Cell Carcinoma in China: A Discrete-Choice Experiment. The Patient - Patient-Centered Outcomes Research.
Crossref
Arianna Dri, Silvio Ken Garattini, Marika Cinausero, Marianna Macerelli, Martina Fanelli, Fabio Puglisi, Gianpiero Fasola & Paola Ermacora. (2022) Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice. Current Oncology 29:10, pages 6776-6786.
Crossref
Mário Fontes-Sousa, Helena Magalhães, Alicia Oliveira, Filipa Carneiro, Filipa Palma dos Reis, Pedro Silvestre Madeira & Sara Meireles. (2022) Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?. Advances in Therapy 39:3, pages 1107-1125.
Crossref
Laura J. Havrilesky, Amelia L. Scott, Brittany A. Davidson, Angeles Alvarez Secord, Jui-Chen Yang, F. Reed Johnson, Juan Marcos Gonzalez & Shelby D. Reed. (2021) The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens. Gynecologic Oncology 162:2, pages 440-446.
Crossref
Alison Pearce, Mark Harrison, Verity Watson, Deborah J. Street, Kirsten Howard, Nick Bansback & Stirling Bryan. (2020) Respondent Understanding in Discrete Choice Experiments: A Scoping Review. The Patient - Patient-Centered Outcomes Research 14:1, pages 17-53.
Crossref
Michael J. Raphael, Andrew Robinson, Christopher M. Booth, Jennifer O’Donnell, Michael Palmer, Elizabeth Eisenhauer & Michael Brundage. (2019) The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer. JAMA Oncology 5:12, pages 1779.
Crossref
Juan Marcos González, Justin Doan, David J. Gebben, Marco Boeri & Mayer Fishman. (2018) Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment. PharmacoEconomics 36:8, pages 973-986.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.